Biochemistry Department

Back to Listing

Biochemistry Seminar: Dr. Craig E. Cameron, The Pennsylvania State University, "mtDNA Mutations and Cancer"

Event Type
Dr. Raven Huang
Charles G. Miller Auditorium, Room B102 Chemical & Life Sciences Laboratory
Oct 18, 2013   12:00 - 1:00 pm  
Dr. Craig E. Cameron
Originating Calendar
Biochemistry Department Seminars

ABSTRACT:  It is well established that somatic mutations are present in mitochondrial DNA (mtDNA) of cells and tissues expressing a variety of different disease phenotypes.  The contribution of these changes to the disease phenotype is not at all clear, if there is a contribution at all.  The primary obstacle to assessing the causal or consequential relationship between somatic mutations in mtDNA and disease is the retrospective nature of the analysis.  Many of the reported somatic mutations in mtDNA are located in a region known as hypervariable region 3 (HVR3).  Often there is concordance in position and substitution between single-nucleotide polymorphisms (SNPs) and somatic mutations observed in HVR3, leading to the possibility that these changes are not of functional significance.  We have obtained biochemical evidence for a role of HVR3 in mitochondrial transcription. Our hypothesis  now is that SNPs and somatic mutations in HVR3 may lead to misregulated transcription and contribute to disease phenotypes. To test this hypothesis, we have used the system described by Ridky et al. (Nat Med. 2010 Dec; 16(12):1450-5.) to establish squamous cell carcinomas ex vivo starting from primary human keratinocytes. This system permits a prospective analysis of changes in mtDNA sequence during the process of tumorigenesis.  We observe mutations in HVR3 reminiscent of those observed retrospectively. To our knowledge, this is the first prospective analysis of the evolution of mtDNA during the transition from a normal to a disease phenotype. The implications of this system and our findings on the consequence of HVR3 mutations will be discussed.

link for robots only